Company: MYSZ
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023456
Chunk: 10

Company: My Size, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 10
---
 such that, beginning on January 1, 2026 and ending on and including January 1,
2029, the share reserve under the Plan will be automatically increased by a number of shares of the Company’s common stock equal
to the lesser of (A) 5% of the aggregate number of shares of the Company’s common stock outstanding on the final day of the immediately
preceding calendar year or (B) such smaller number of shares as is determined by the Company’s board of directors.

On
February 14, 2024, the Compensation Committee of the Company granted restricted common stock awards under the Company’s 2017 Equity
Incentive Plan to Ronen Luzon, Oren Elmaliah and Billy Pardo, pursuant to which they were issued 37,500
restricted shares, 18,750
restricted shares and 18,750
restricted shares, respectively. The restricted shares shall
vest in three equal installments on January 1, 2025, January 1, 2026 and January 1, 2027, conditioned upon continuous employment with
the Company and subject to accelerated vesting upon a change in control of the Company. On the same day, the Company granted a total
of 10,000
restricted stock units (“RSUs”) to its directors
that will vest on January 1, 2025 and 5five-years options to purchase up to 6,875 shares of common stock to other employees of the Company
at an exercise price of $3.832 per share. The option vesting period is over three years in three equal portions from the vesting commencement
date.

The
compensation cost resulting from the grant is approximately $314 and is expected to be recognized over a period of 3 years.

The
fair value of each option award is estimated on the date of grant using the Binomial option-pricing model that used the weighted average
assumptions in the following table. The risk free rate for the expected term of the option is based on the U.S. Treasury yield curve
in effect at the time of grant.

Schedule
of Fair Value Assumptions of Stock Option

    2024
    Grants 
  
    Dividend yield 
     0%
  
    Expected volatility 
     86.22%
  
    Risk-free interest 
     4.3%
  
    Contractual term 
     2.0-2.8 

    2025
    Repricing